Research has revealed a significant upregulation of CCNA2 mRNA and lncRNA DNAH17 antisense RNA 1 (DNAH17-AS1) in NSCLC specimens and cell lines, accompanied by a notable decrease in miR-877-5p expression. This evidence concerns the gene DNAH17-AS1 and non-small cell lung carcinoma.